|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Calcbench Looks to Help Budget-Minded Analysts Crunch Financial Data
|
Erin Kutz |
11/08/11 |
Boston
|
|
Venture Industry Calls for Rules Changes to Reopen IPO Market
|
Wade Roush |
10/20/11 |
National
|
|
Sequenom Inaugurates New Diagnostic Test for Down Syndrome
|
Bruce V. Bigelow |
10/17/11 |
San Diego
|
|
Y Combinator’s Summer 2011 Demo Day: The Definitive Debrief, Part 1
|
Wade Roush |
08/24/11 |
San Francisco
|
|
SecondMarket Attempts to Sell Startups on the Value of Letting Employees Trade Their Stock
|
Wade Roush |
08/18/11 |
San Francisco
|
|
Metabolic Solutions Raises Another $6.8M
|
Sarah Schmid |
08/15/11 |
Detroit
|
|
Venture-Backed Buyouts at Record Volume as Increasing Pace of Exits Mark Possible Recovery
|
Bruce V. Bigelow |
01/03/11 |
National
|
|
Filing: Webfilings Adds $5.1M
|
Wade Roush |
07/12/10 |
San Francisco
|
|
Feds’ Sequenom Probe Breaks Into the Open, Life Technologies Moves Into Synthetic Biology, DexCom Agrees to Re-Label Its Medical Devices, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
06/03/10 |
San Diego
|
|
Startup Elcelyx Raises $1.2 Million
|
Denise Gellene |
03/18/10 |
San Diego
|
|
Sequenom Down Syndrome Results “Deliberately Doctored,” Says Partner Xenomics
|
Luke Timmerman |
12/17/09 |
San Diego
|
|
UK’s Enigma Looks to San Diego, Life Gets Sweeter for Senomyx, Arena Says Obesity Drug Is Not “Wimpy,” & More San Diego Life Sciences News
|
Denise Gellene |
10/29/09 |
San Diego
|
|
Optherion Sells $5M in Convertible Notes and Warrants
|
Ryan McBride |
09/17/09 |
Boston
|
|
Of Phase Forward, MedVentive, and iMedX—Today’s New England Heath IT Deals Round-Up
|
Ryan McBride |
07/15/09 |
Boston
|
|
Salient Surgical Cuts $86M IPO
|
Ryan McBride |
08/27/08 |
Boston
|
|
Exact Sciences Puts Itself on the Block After Investor’s Prodding
|
Rebecca Zacks |
03/18/08 |
Boston
|
|
Biogen’s Busy Week, Alnylam’s Big Announcement, Targanta’s and Momenta’s Growing Executive Ranks, & More Life Sciences News
|
Rebecca Zacks |
03/05/08 |
Boston
|
|
Verenium Files $150 Million Shelf Registration
|
Rebecca Zacks |
11/15/07 |
Boston
|
|
Genzyme CEO Nets $9.3 Million From Options
|
Rebecca Zacks |
10/31/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
